Please assess the completion status of the following clinical trial:

Trial Title: Novel Biomarkers of Thrombotic Risk

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Myocardial infarction demonstrated by elevated markers of cardiac injury (troponin I (TNI) or creatine kinase (CK) MB fraction)~* the presence of coronary artery disease demonstrated by cardiac catheterization or perfusion imaging~Exclusion Criteria:~* Treatment with long term anticoagulants~* active infection~* malignancy

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).